ES8702891A1 - Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina - Google Patents

Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina

Info

Publication number
ES8702891A1
ES8702891A1 ES553086A ES553086A ES8702891A1 ES 8702891 A1 ES8702891 A1 ES 8702891A1 ES 553086 A ES553086 A ES 553086A ES 553086 A ES553086 A ES 553086A ES 8702891 A1 ES8702891 A1 ES 8702891A1
Authority
ES
Spain
Prior art keywords
atoms
nitro
hydrogen
image
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES553086A
Other languages
English (en)
Other versions
ES553086A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES553086A0 publication Critical patent/ES553086A0/es
Publication of ES8702891A1 publication Critical patent/ES8702891A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE 3-NITRO-DIHIDROPIRIDINA, DE FORMULA (I), Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES. CONSISTE EN LA REACCION DE ESTERIFICACION DE UN DERIVADO REACTIVO DE UN ACIDO CARBOXILICO, DE FORMULA (II), CON UN COMPUESTO DE FORMUYLA H-X-A-R3, PARA FORMAR UN COMPUESTO DE FORMULA (I) EN LA QUE X REPRESENTA OXIGENO O AZUFRE Y R1, R2, R3 Y A PUEDEN SER VARIOS TIPOS DE RADICALES. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE, A UNA TEMPERATURA COMPRENDIDA ENTRE 10JC Y 150JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU EFECTO INOTROPO POSITIVO SOBRE EL SISTEMA CIRCULATORIO.
ES553086A 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina Expired ES8702891A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843420784 DE3420784A1 (de) 1984-06-04 1984-06-04 3-nitro-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES553086A0 ES553086A0 (es) 1987-01-16
ES8702891A1 true ES8702891A1 (es) 1987-01-16

Family

ID=6237588

Family Applications (6)

Application Number Title Priority Date Filing Date
ES543838A Expired ES8607239A1 (es) 1984-06-04 1985-06-03 Derivados de la 3-nitro-dihidropiridina
ES553086A Expired ES8702891A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina
ES553089A Expired ES8702358A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina
ES553085A Expired ES8702356A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina
ES553088A Expired ES8702357A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina
ES553087A Expired ES8702892A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES543838A Expired ES8607239A1 (es) 1984-06-04 1985-06-03 Derivados de la 3-nitro-dihidropiridina

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES553089A Expired ES8702358A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina
ES553085A Expired ES8702356A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina
ES553088A Expired ES8702357A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina
ES553087A Expired ES8702892A1 (es) 1984-06-04 1986-03-17 Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina

Country Status (16)

Country Link
US (1) US4645775A (es)
EP (1) EP0164010B1 (es)
JP (1) JPH0670013B2 (es)
KR (1) KR860000262A (es)
AT (1) ATE40883T1 (es)
AU (1) AU4329485A (es)
DE (2) DE3420784A1 (es)
DK (1) DK248585A (es)
ES (6) ES8607239A1 (es)
FI (1) FI852204L (es)
GR (1) GR851313B (es)
HU (1) HU193986B (es)
IL (1) IL75364A0 (es)
NO (1) NO852024L (es)
PT (1) PT80579B (es)
ZA (1) ZA854163B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
DE3732380A1 (de) * 1987-09-25 1989-04-06 Bayer Ag Dihydropyridinether, verfahren zu ihrer herstellung und ihre verwendung
JPH02167262A (ja) * 1988-06-05 1990-06-27 Taisho Pharmaceut Co Ltd 1,4―ジヒドロピリジン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3319956A1 (de) * 1983-06-01 1984-12-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
FR2554109A1 (fr) * 1983-11-01 1985-05-03 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments

Also Published As

Publication number Publication date
ES543838A0 (es) 1986-06-16
IL75364A0 (en) 1985-09-29
ES553086A0 (es) 1987-01-16
ES553088A0 (es) 1987-01-01
ES8702357A1 (es) 1987-01-01
EP0164010A2 (de) 1985-12-11
DK248585A (da) 1985-12-05
ES8702356A1 (es) 1987-01-01
JPH0670013B2 (ja) 1994-09-07
GR851313B (es) 1985-11-25
ES8702358A1 (es) 1987-01-01
NO852024L (no) 1985-12-05
DE3568330D1 (en) 1989-03-30
EP0164010B1 (de) 1989-02-22
AU4329485A (en) 1985-12-12
ATE40883T1 (de) 1989-03-15
ES8702892A1 (es) 1987-01-16
DK248585D0 (da) 1985-06-03
PT80579A (en) 1985-07-01
FI852204L (fi) 1985-12-05
ZA854163B (en) 1986-01-29
JPS611660A (ja) 1986-01-07
ES553085A0 (es) 1987-01-01
FI852204A0 (fi) 1985-05-31
US4645775A (en) 1987-02-24
KR860000262A (ko) 1986-01-27
ES553087A0 (es) 1987-01-16
DE3420784A1 (de) 1985-12-05
HU193986B (en) 1987-12-28
HUT38313A (en) 1986-05-28
PT80579B (en) 1987-04-28
ES8607239A1 (es) 1986-06-16
EP0164010A3 (en) 1987-08-05
ES553089A0 (es) 1987-01-01

Similar Documents

Publication Publication Date Title
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES481126A1 (es) Procedimiento para la preparacion de nuevos derivados fe- nilpiperazinicos.
ES8402560A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
ES8107216A1 (es) Procedimiento para la preparacion de sulfonilureas
MX9206082A (es) Derivados de amida de acido n-fenil-2-ciano-3-hidroxicrotonico y su empleo como medicamentos con propiedades inmunomoduladoras.
ES8702358A1 (es) Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina
ES8105993A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES474694A1 (es) Un procedimiento de preparacion de nuevos derivados de las 5h-benzociclohepten-7-amina
ES8105998A1 (es) Un procedimiento para la produccion de nuevos derivados de 6-alquil-7-fenil-1,6-naftiridin-5(6h)-ona y sus sales de adi-cion de acidos.
DE3474669D1 (en) 1,4-dihydropyridines, method for their preparation and their use as medicaments
ATE101119T1 (de) Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
ES2009283A6 (es) Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal.